Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab

William E. Pierceall; Nizar Bahlis; David S Siegel; Gary J. Schiller; Christy J. Samaras; Michael Sebag; Jesus G. Berdeja; Siddhartha Ganguly; Jeffrey V Matous; Kevin Song; Christopher S. Seet; Giampaolo Talamo; Shanti Srinivas; Shanti Srinivas; Mirelis Acosta-Rivera; Michael Bar; Donald P. Quick; Bertrand Anz; Gustavo Fonseca; Donna Reece; Weiyuan Chung; Natalya Serbina; Faiza Zafar; Amit Agarwal; Anjan Thakurta

doi:10.1182/BLOOD-2018-99-111554

Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab

William E. Pierceall
, Nizar Bahlis
, David S Siegel
, Gary J. Schiller
, Christy J. Samaras
, Michael Sebag
, Jesus G. Berdeja
, Siddhartha Ganguly
, Jeffrey V Matous
, Kevin Song
, Christopher S. Seet
, Giampaolo Talamo
, Shanti Srinivas
, Shanti Srinivas
, Mirelis Acosta-Rivera
, Michael Bar
, Donald P. Quick
, Bertrand Anz
, Gustavo Fonseca
, Donna Reece

Weiyuan Chung, Natalya Serbina, Faiza Zafar, Amit Agarwal, Anjan Thakurta

Celgene
University of Calgary
Hackensack University Medical Center
University of California, Los Angeles
Cleveland Clinic
McGill University Health Centre
Sarah Cannon Research Institute
University of Kansas
Colorado Blood Cancer Institute, Denver, CO
Vancouver General Hospital
Penn State Cancer Institute
Rutgers University
Veterans Health Administration
Fundacion de Investigacion, San Juan, Puerto Rico
Stamford Hospital
Joe Arrington Cancer Research Treatment Center, Lubbock, TX
Tennessee Oncology, Chattanooga, TN
Florida Cancer Specialists, St Petersburg, FL
Princess Margaret Cancer Centre

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	132
DOIs	https://doi.org/10.1182/BLOOD-2018-99-111554
State	Published - Nov 29 2018
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1182/BLOOD-2018-99-111554License: Unspecified

Cite this

Pierceall, W. E., Bahlis, N., Siegel, D. S., Schiller, G. J., Samaras, C. J., Sebag, M., Berdeja, J. G., Ganguly, S., Matous, J. V., Song, K., Seet, C. S., Talamo, G., Srinivas, S., Srinivas, S., Acosta-Rivera, M., Bar, M., Quick, D. P., Anz, B., Fonseca, G., ... Thakurta, A. (2018). Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab. Blood, 132. https://doi.org/10.1182/BLOOD-2018-99-111554

Pierceall, WE, Bahlis, N, Siegel, DS, Schiller, GJ, Samaras, CJ, Sebag, M, Berdeja, JG, Ganguly, S, Matous, JV, Song, K, Seet, CS, Talamo, G, Srinivas, S, Srinivas, S, Acosta-Rivera, M, Bar, M, Quick, DP, Anz, B, Fonseca, G, Reece, D, Chung, W, Serbina, N, Zafar, F, Agarwal, A & Thakurta, A 2018, 'Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab', Blood, vol. 132. https://doi.org/10.1182/BLOOD-2018-99-111554

@article{1fd8758797154fa69323f66b2b0b0a43,

title = "Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab",

author = "Pierceall, \{William E.\} and Nizar Bahlis and Siegel, \{David S\} and Schiller, \{Gary J.\} and Samaras, \{Christy J.\} and Michael Sebag and Berdeja, \{Jesus G.\} and Siddhartha Ganguly and Matous, \{Jeffrey V\} and Kevin Song and Seet, \{Christopher S.\} and Giampaolo Talamo and Shanti Srinivas and Shanti Srinivas and Mirelis Acosta-Rivera and Michael Bar and Quick, \{Donald P.\} and Bertrand Anz and Gustavo Fonseca and Donna Reece and Weiyuan Chung and Natalya Serbina and Faiza Zafar and Amit Agarwal and Anjan Thakurta",

note = "William E. Pierceall, Nizar Bahlis, David S Siegel, Gary J. Schiller, Christy J. Samaras, Michael Sebag, Jesus G. Berdeja, Siddhartha Ganguly, Jeffrey V Matous, Kevin Song, Christopher S. Seet, Giampaolo Talamo, Shanti Srinivas, Mirelis Acosta-Rivera, Michael Bar, Donald P.",

year = "2018",

month = nov,

day = "29",

doi = "10.1182/BLOOD-2018-99-111554",

language = "American English",

volume = "132",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab

AU - Pierceall, William E.

AU - Bahlis, Nizar

AU - Siegel, David S

AU - Schiller, Gary J.

AU - Samaras, Christy J.

AU - Sebag, Michael

AU - Berdeja, Jesus G.

AU - Ganguly, Siddhartha

AU - Matous, Jeffrey V

AU - Song, Kevin

AU - Seet, Christopher S.

AU - Talamo, Giampaolo

AU - Srinivas, Shanti

AU - Acosta-Rivera, Mirelis

AU - Bar, Michael

AU - Quick, Donald P.

AU - Anz, Bertrand

AU - Fonseca, Gustavo

AU - Reece, Donna

AU - Chung, Weiyuan

AU - Serbina, Natalya

AU - Zafar, Faiza

AU - Agarwal, Amit

AU - Thakurta, Anjan

N1 - William E. Pierceall, Nizar Bahlis, David S Siegel, Gary J. Schiller, Christy J. Samaras, Michael Sebag, Jesus G. Berdeja, Siddhartha Ganguly, Jeffrey V Matous, Kevin Song, Christopher S. Seet, Giampaolo Talamo, Shanti Srinivas, Mirelis Acosta-Rivera, Michael Bar, Donald P.

PY - 2018/11/29

Y1 - 2018/11/29

UR - https://ashpublications.org/blood/article/132/Supplement%201/2012/261814/Immune-Profiling-of-Relapsed-or-Refractory

U2 - 10.1182/BLOOD-2018-99-111554

DO - 10.1182/BLOOD-2018-99-111554

M3 - Article

VL - 132

JO - Blood

JF - Blood

ER -

Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab

Disciplines

Access to Document

Other files and links

Cite this